What is Royalty Pharma's quarterly conversion basis (in shares)?

Royalty Pharma (RPRX) reported quarterly conversion basis (in shares) of 100.0% in Q1 2026.

How has Royalty Pharma's quarterly conversion basis (in shares) changed year-over-year?

Royalty Pharma's quarterly conversion basis (in shares) decreased by 0.0% year-over-year, from 100.0% to 100.0%.

Quarterly conversion basis (in shares)

Royalty Pharma Quarterly conversion basis (in shares) remained flat by 0.0% to 100.0% in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 100.0% to 100.0%.

Analysis

StatementBalance Sheet Statement

SectionOther

First reportedQ2 2022

Last reportedQ1 2026

Metric ID: other_common_stock_quarterly_conversion_basis

Historical Data

12 periods

	Q2 '22	Q3 '22	Q1 '23	Q2 '23	Q3 '23	Q1 '24	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25	Q1 '26
Value	100%	100%	100%	100%	100%	100%	100%	100%	100%	100%	100%	100%
QoQ Change	—	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%
YoY Change	—	—	—	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%

Range100% – 100%

CAGR+0.0%

Avg YoY Growth+0.0%

Median YoY Growth+0.0%

Current Streak11+ quarters growth

Frequently Asked Questions

What is Royalty Pharma's quarterly conversion basis (in shares)?: Royalty Pharma (RPRX) reported quarterly conversion basis (in shares) of 100.0% in Q1 2026.
How has Royalty Pharma's quarterly conversion basis (in shares) changed year-over-year?: Royalty Pharma's quarterly conversion basis (in shares) decreased by 0.0% year-over-year, from 100.0% to 100.0%.